PMC3909476_01
Computed tomography before and after treatment. Pre-treatment images showed enlarged mediastinal (A, arrows), para-aortic (B, arrows), and iliac (C, arrows) lymph nodes. Images nine months after ADT showed a partial response of the mediastinal (D, arrows), para-aortic (E, arrows), and iliac (F, arrows) lymph nodes.
1756-0500-7-64-1.jpg
PMC3909476_01_1756-0500-7-64-1.jpg
F1
Computed tomography showed enlarged mediastinal, para-aortic, and iliac lymph nodes (Figure 1A,B,C). Nine months after the initial prostate biopsy, his enlarged lymph nodes had shrunk in size (Figure 1D,E,F) and his PSA level had decreased to 4.8 ng/mL.
Bone scintigraphy (A) and magnetic resonance imaging (B, C) showed osteoblastic lumbar spine metastases (arrows).
1756-0500-7-64-2.jpg
PMC3909476_01_1756-0500-7-64-2.jpg
F2
Bone scintigraphy and magnetic resonance imaging showed osteoblastic lumber spine metastases (Figure 2).
Histopathological examination findings. The first 10-core (A) and second 12-core (B) transrectal prostate biopsies and the transurethral resection biopsy (5 g) (C) showed benign prostatic hyperplasia. The estimated total weight of the prostate at the time of transurethral resection was 16 g. The 34betaE12 anti-cytokeratin monoclonal antibody was positive in all specimens. Original magnification: x40.
1756-0500-7-64-3.jpg
PMC3909476_01_1756-0500-7-64-3.jpg
F3
Ten-core transrectal prostate biopsy yielded negative results (Figure 3A). The resected transurethral specimen weighed 5 g (the estimated total weight of the prostate: 16 g), but did not contain prostate cancer tissue (Figure 3B,C). The patient refused further prostate cancer screening because ADT effectively relieved his symptoms.